Skip to content

Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US Adults

A Propensity-Matched Retrospective Cohort Study of Antidepressant Drug Exposure and Risk of Suicide Attempt in Adults From a Large U.S. Managed Care Population

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00763724
Enrollment
254432
Registered
2008-10-01
Start date
2008-06-30
Completion date
2009-11-30
Last updated
2010-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Suicide

Brief summary

The primary objective of the study is to estimate the incidence of suicide attempts resulting in a medical encounter or hospitalization in seven propensity matched cohorts of subjects: patients treated with duloxetine for depression, patients treated with one of three other antidepressants or antidepressant classes (venlafaxine, SSRIs, or TCAs) for depression, patients treated with multiple antidepressants for depression (either concurrently or consecutively), depressed patients with no pharmacologic treatment, and a non-depressed general population sample.

Interventions

None listed

Sponsors

Eli Lilly and Company
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older at index date * Have at least 6 months of continuous enrollment data prior to index date. * Have complete medical, facility, and pharmacy records (the latter of which will include complete quantity and days supplied information).

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Incidence of suicide attempt resulting in medical encounter or hospitalization.Endpoint

Secondary

MeasureTime frame
Relative risk of suicide attempt resulting in medical encounters or hospitalizationEndpoint

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026